Sign In
Buy KURA
$8.66
-0.315 (-3.51%)
At Close: Jun 03, 2026
Did Hedge Funds Make The Right Call On Kura Oncology, Inc. (KURA) ?
02:37pm, Friday, 17'th Jul 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Zacks Investment Research Lowers Kura Oncology (NASDAQ:KURA) to Hold
06:36pm, Wednesday, 15'th Jul 2020
Kura Oncology (NASDAQ:KURA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, �
Squarepoint Ops LLC Has $911,000 Stock Holdings in Kura Oncology Inc (NASDAQ:KURA)
10:38am, Sunday, 28'th Jun 2020
Squarepoint Ops LLC lessened its holdings in Kura Oncology Inc (NASDAQ:KURA) by 29.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commissi
Hedge Funds Aren’t Done Buying Kura Oncology, Inc. (KURA)
02:46pm, Tuesday, 16'th Jun 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Kura Oncology Inc (NASDAQ:KURA) Stake Lifted by Citigroup Inc.
06:02am, Tuesday, 16'th Jun 2020
Citigroup Inc. raised its stake in Kura Oncology Inc (NASDAQ:KURA) by 68.9% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 21,798 shares of the company�
Kura Oncology to Participate in JMP Securities Hematology & Oncology Forum
12:35pm, Thursday, 11'th Jun 2020
SAN DIEGO, June 11, Jun 11, 2020 (GLOBE NEWSWIRE via COMTEX) --
SAN DIEGO, June 11, 2020 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a...
Kura Oncology to Participate in JMP Securities Hematology & Oncology Forum
11:30am, Thursday, 11'th Jun 2020
Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of
Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced updated clinical outcome d
The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
12:00am, Friday, 29'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 28)
ADC Therapeutics SA (NYSE:...
Kura Oncology Announces Three Abstracts Accepted for Presentation at ASCO20 Virtual Scientific Program
09:00pm, Wednesday, 13'th May 2020
Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that three abstracts highl
Edited Transcript of KURA earnings conference call or presentation 4-May-20 8:30pm GMT
07:18am, Wednesday, 13'th May 2020
Q1 2020 Kura Oncology Inc Earnings Call
Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
08:03pm, Friday, 08'th May 2020
SAN DIEGO, May 08, 2020 -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the.
Kura Oncology to Present at BofA Securities Virtual Health Care Conference 2020
11:30am, Thursday, 07'th May 2020
Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation at the B
Kura Oncology Announces Pricing of $125 Million Public Offering of Common Stock
01:00pm, Wednesday, 06'th May 2020
Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced the pricing of an underwri
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
